alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › biomarkers-candidate

biomarkers-candidate

3 studies tagged biomarkers-candidate, dated 2010-11-25 to 2018-12-08. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease 2018-12-08
  2. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study 2018-04-11
  3. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics 2010-11-25

Studies

3 studies carry this tag.

Date range

2010 to 2018

Top journals

  • Alzheimer's research & therapy 1
  • Journal of proteomics 1
  • PloS one 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's research & therapy 2018-12-08 Biomarkers

    The measurement of plasma Aβ peptides with an immunological assay can be improved by preconcentration via immunoprecipitation with an antibody against the Aβ amino-terminus and elution of the captured peptides by heating in a mild detergent-containing buffer.

  2. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study

    ✓ Peer-reviewed alzhub usefulness score 62 out of 100. PloS one 2018-04-11 Biomarkers

    Measurement of tau in serum is feasible.

  3. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of proteomics 2010-11-25 Genetics

    There is an urgent need for novel biomarkers that can be used to improve the diagnosis, predict the disease progression, improve our understanding of the pathology or serve as therapeutic targets for neurodegenerative diseases.

All topic tags with their study counts